Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Current assets:
Cash and cash equivalents	$ 33,087	$ 20,764
Accounts receivable, net	38,378	60,942
Other receivables	4,161	11,304
Deferred cost of sales	0	14,113
Inventories, net	20,021	16,812
Other current assets	2,990	2,794
Total current assets	98,637	126,729
Property and equipment, net	6,713	6,134
Intangible assets, net	17,575	30,322
Long-term deferred tax assets, net	1,117	1,173
Other assets	4,143	2,711
Total assets	128,185	167,069
Current liabilities:
Accounts payable	20,805	43,451
Accrued wages and bonuses	6,572	7,250
Deferred revenue	5,715	23,062
Line of credit	25,000	15,000
Other accrued liabilities	7,571	9,404
Total current liabilities	65,663	98,167
Long-term liabilities:
Other long-term liabilities	5,966	2,985
Total long-term liabilities	5,966	2,985
Total liabilities	71,629	101,152
Commitments and contingencies (Note 13)
Shareholders’ equity:
Preferred stock — $0.01 par value, 5,664 shares authorized; none issued or outstanding at December 31, 2016 and December 31, 2015	0	0
Common stock — no par value, 100,000 shares authorized; 38,521 and 36,959 shares issued and outstanding at December 31, 2016 and December 31, 2015	339,715	338,165
Accumulated deficit	(281,600)	(271,349)
Accumulated other comprehensive loss:
Cumulative translation adjustments	(1,032)	(80)
Unrealized loss on hedge instruments	(527)	(819)
Total accumulated other comprehensive loss	(1,559)	(899)
Total shareholders’ equity	56,556	65,917
Total liabilities and shareholders’ equity	$ 128,185	$ 167,069